{
  "meta": {
    "title": "94_Chronic_Myeloid_Leukemia_And_Chronic_Lymphoid_Leukemia",
    "url": "https://brainandscalpel.vercel.app/94-chronic-myeloid-leukemia-and-chronic-lymphoid-leukemia-683cf6c5.html",
    "scrapedAt": "2025-11-30T12:29:19.079Z"
  },
  "questions": [
    {
      "text": "Which of the following patients are at risk of developing chronic myeloid leukemia?",
      "choices": [
        {
          "id": 1,
          "text": "A middle-aged man whose mother died of chronic myeloid leukemia"
        },
        {
          "id": 2,
          "text": "An oil-refinery worker with occupational benzene exposure for 20 years"
        },
        {
          "id": 3,
          "text": "A woman who underwent radiotherapy for carcinoma cervix"
        },
        {
          "id": 4,
          "text": "An elderly man who received chemotherapy for Hodgkin's lymphoma"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Exposure</strong> to a high dose of&nbsp;<strong>ionizing radiation</strong> is the only known risk factor for developing chronic myeloid leukemia (<strong>CML</strong>). This may be in the form of radiation therapy for malignancy or other conditions and nuclear accidents. It is <strong>dose-dependent</strong> and low-dose&nbsp;radiation exposure is not a risk factor.</p>\n<p>There are no familial associations, infections, or toxins associated with the development of CML.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4185",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is true about the Philadelphia chromosome?",
      "choices": [
        {
          "id": 1,
          "text": "Unbalanced translocation between short arm of chromosomes 9 and 22"
        },
        {
          "id": 2,
          "text": "Unbalanced translocation between long arm of chromosomes 9 and 22"
        },
        {
          "id": 3,
          "text": "Balanced translocation between short arm of chromosomes 9 and 22"
        },
        {
          "id": 4,
          "text": "Balanced translocation between long  arm of chromosomes 9 and 22"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Philadelphia chromosome is a <strong>balanced</strong>&nbsp;translocation between the&nbsp;<strong>long arm</strong> of chromosomes <strong>9</strong> and <strong>22.&nbsp;</strong>It is present in the majority of patients with chronic myeloid leukemia (<strong>CML</strong>).</p>\n<p>In a balanced translocation, a part of one chromosome is shifted to another chromosome and vice versa. In this case, the&nbsp;<strong>ABL </strong>gene present in chromosome 9 is translocated next to the <strong>BCR gene</strong> (breakpoint cluster region)&nbsp;on chromosome 22. It leads to the formation of&nbsp;<strong>shortened</strong> chromosome 22, which has been named the Philadelphia chromosome&nbsp;after the place of discovery.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1b2167583b68450cabe080e164d59580x1280x2541.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4186",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common sign in patients with chronic myeloid leukemia?",
      "choices": [
        {
          "id": 1,
          "text": "Lymphadenopathy"
        },
        {
          "id": 2,
          "text": "Hepatomegaly"
        },
        {
          "id": 3,
          "text": "Splenomegaly"
        },
        {
          "id": 4,
          "text": "Weight loss"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Splenomegaly</strong> is the most common physical examination finding in patients with chronic myeloid leukemia (<strong>CML</strong>).</p>\n<p>The majority of the patients with CML are <strong>asymptomatic</strong>. They are often incidentally diagnosed during routine blood tests when they have elevated white blood cells count. In later stages, the following clinical features develop:</p>\n<ul>\n<li><strong>Anemia</strong> - easy fatigability, exercise intolerance</li>\n<li>Increased number of WBCs and platelets - <strong>hyperviscosity</strong>, leading to MI and stroke</li>\n<li>Increased cell metabolism - night sweats, weight loss, and <strong>hyperuricemia</strong> (gout)</li>\n<li>Splenomegaly -&nbsp;abdominal pain, early satiety</li>\n<li>Hepatomegaly, lymphadenopathy, skin or subcutaneous lesions&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4187",
      "difficulty": "medium"
    },
    {
      "text": "Leukocyte alkaline phosphatase score is decreased in patients with all of the following except:",
      "choices": [
        {
          "id": 1,
          "text": "Chronic myeloid leukemia"
        },
        {
          "id": 2,
          "text": "Paroxysmal nocturnal hemoglobinuria"
        },
        {
          "id": 3,
          "text": "Sickle cell anemia"
        },
        {
          "id": 4,
          "text": "Polycythemia vera"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Leukocyte alkaline phosphatase (<strong>LAP</strong>) <strong>score</strong> is <strong>increased</strong> in <strong>polycythemia vera</strong> and leukemoid reactions<strong>.</strong></p>\n<p>The biochemical abnormalities in <strong>CML</strong> include:</p>\n<ul>\n<li><strong>Low LAP score</strong></li>\n<li>High levels of:\n<ul>\n<li>Vitamin B12</li>\n<li>Uric acid</li>\n<li>Lactic dehydrogenase</li>\n<li>Lysozyme</li>\n</ul>\n</li>\n</ul>\n<p>Note:<strong> Leukemoid reaction&nbsp;</strong>refers to extreme elevations in <strong>WBC &gt; 50,000/mm<sup>3</sup></strong> due to reactive causes outside the marrow. This includes severe infection, trauma, Down's syndrome.</p><hr><h3>Related Pearl: Leucocyte Alkaline Phosphatase Score</h3><p>Alkaline phosphatase activity is found predominantly in&nbsp;<strong>mature segmented neutrophils</strong>. LAP score is obtained by assessing the&nbsp;<strong>staining intensity</strong>&nbsp;in 100 consecutive neutrophils, with each neutrophil scored on a scale of 1&ndash;4.&nbsp;</p>\n<p><strong>Conditions</strong> that result in an <strong>increase</strong> in <strong>leukocytes</strong> in all stages of maturity will reflect a corresponding <strong>increase</strong> in <strong>LAP</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Elevated LAP score</strong></p>\n</td>\n<td>\n<p><strong>Decreased LAP score</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Leukemoid reaction</p>\n</td>\n<td>\n<p>Chronic myeloid leukemia (CML)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pregnancy</p>\n</td>\n<td>\n<p>Paroxysmal nocturnal hemoglobinuria</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia vera</p>\n</td>\n<td>\n<p>Sickle cell anemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Multiple myeloma</p>\n</td>\n<td>\n<p>Hypophosphatasia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Obstructive jaundice</p>\n</td>\n<td>\n<p>Aplastic anemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hodgkin lymphoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4188",
      "difficulty": "medium"
    },
    {
      "text": "In patients with chronic myeloid leukemia, which of the following are predominantly elevated in the peripheral smear?",
      "choices": [
        {
          "id": 1,
          "text": "Segmented neutrophils"
        },
        {
          "id": 2,
          "text": "Metamyelocytes"
        },
        {
          "id": 3,
          "text": "Myelocytes"
        },
        {
          "id": 4,
          "text": "Band  forms"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Myelocytes</strong> will be <strong>predominantly elevated</strong> in the <strong>peripheral smear</strong> of the patients with chronic myeloid leukemia (<strong>CML</strong>).</p>\n<p>The clinical hallmark of CML is the uncontrolled production of mature and maturing granulocytes. All of the stages of development of granulocytes can be noted on the peripheral smear in varying numbers:</p>\n<ul>\n<li><strong>Myeloblast </strong>- large cells with a round or oval nucleus, cytoplasm is dark and has <strong>no granules</strong></li>\n<li><strong>Myelocyte </strong>- nucleus is <strong>oval</strong> and is eccentrically placed.</li>\n<li><strong>Metamyelocyte </strong>- nucleus is like a <strong>kidney bean</strong>-shaped </li>\n<li><strong>Band forms </strong>- nucleus is in the shape of <strong>C </strong>or<strong> U</strong>.</li>\n<li>Segmented neutrophils- nucleus has <strong>2-5 lobes</strong>.</li>\n</ul>\n<p>All the cells except the myeloblast have a <strong>granular</strong> cytoplasm. Due to the varied appearance of the cells, it is called <strong>garden party </strong>appearance or <strong>college girl's </strong>appearance.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c80a1c5a9d214659b17142f665e788e1x1280x1117.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2357",
      "difficulty": "hard"
    },
    {
      "text": "A 55-year-old man is found to have the following findings on a routine CBC. A subsequent peripheral smear is performed as shown below. A bone marrow aspiration study is planned for this patient. All of the following are likely to be seen on bone marrow except:<div class='question-desc-html'><p>Hemoglobin - 8.4 g/dL</p>\n<p>WBC count - 1,65,000/cu.mm</p>\n<p>Platelet count - 6,10,000/cu.mm</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Hypercellular bone marrow"
        },
        {
          "id": 2,
          "text": "Myeloid: Erythroid ratio of 15:1"
        },
        {
          "id": 3,
          "text": "Marrow blasts >20 %"
        },
        {
          "id": 4,
          "text": "Sea-blue histiocytes"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The image shows a<strong> left-shift</strong> with a predominance of segmented neutrophils, myelocytes, metamyelocytes that is suggestive of <strong>chronic myeloid</strong> <strong>leukemia</strong> (CML). <strong>Marrow blasts </strong>are usually <strong>&lt; 5%</strong> in the majority of CML patients.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/af8aa583bc3c45d494bb2e06e5d68374x1280x1117.JPEG\" alt=\"Explanation Image\"><p>In CML, the following bone marrow findings are noted:</p>\n<ul>\n<li>Markedly <strong>hypercellularity</strong> - due to increased <strong>granulocytic</strong> precursors\n<ul>\n<li>Myeloid: erythroid ratio (<strong>M/E ratio</strong>) is significantly <strong>increased</strong> </li>\n<li>Megakaryocytes - normal or increased</li>\n<li>Erythroid precursors - usually decreased</li>\n</ul>\n</li>\n<li><strong>Sea blue histiocytes </strong>- macrophages with abundant wrinkled, green-blue cytoplasm.</li>\n<li>Bone marrow fibrosis may occur due to the deposition of reticulin.</li>\n<li><strong>Pseudo-Gaucher cells </strong>- macrophages with wrinkled tissue paper appearance, as shown below. Due to the increased turnover of the cells, there is an increased accumulation of glucocerebroside within the macrophages.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/724372ce4d5d41cab064bd8a0bf9cd75x436x356.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/953efa8ae72047358cfdecce702a4cc6.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4189",
      "difficulty": "medium"
    },
    {
      "text": "A 48-year-old man presents to the clinic with easy fatiguability and weight loss. After a detailed workup, he is diagnosed with chronic myeloid leukemia. What is the initial treatment of choice?",
      "choices": [
        {
          "id": 1,
          "text": "Allogeneic stem cell transplantation"
        },
        {
          "id": 2,
          "text": "Monoclonal antibody against C5"
        },
        {
          "id": 3,
          "text": "Tyrosine kinase inhibitor"
        },
        {
          "id": 4,
          "text": "CD20 inhibitor"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>initial treatment</strong> of choice in patients with chronic myeloid leukemia (<strong>CML</strong>) is <strong>tyrosine kinase inhibitors</strong>. These include imatinib, nilotinib, dasatinib, bosutinib, and ponatinib.</p>\n<p><strong>Allogeneic stem cell transplant</strong> is considered in patients who are <strong>negative</strong> for <strong>Philadelphia</strong> <strong>chromosome</strong>, or who are non-responsive to the tyrosine kinase inhibitors.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4190",
      "difficulty": "easy"
    },
    {
      "text": "A 61-year-old with CML failed to respond to imatinib therapy. Further evaluation revealed a T315I mutation. What drug should he be started on?",
      "choices": [
        {
          "id": 1,
          "text": "Bosutinib"
        },
        {
          "id": 2,
          "text": "Nilotinib"
        },
        {
          "id": 3,
          "text": "Omacetaxine"
        },
        {
          "id": 4,
          "text": "Ponatinib"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Ponatinib</strong>&nbsp;is effective in patients with&nbsp;<strong>CML</strong> with <strong>T315I mutations.&nbsp;</strong>It is a third-generation tyrosine kinase inhibitor.</p>\n<p>The T315I mutation in BCR-ABL clones is specifically <strong>resistant</strong> to therapy with <strong>imatinib</strong>, dasatinib, nilotinib, and bosutinib but is <strong>sensitive </strong>to the <strong>third</strong>-<strong>generation</strong> agent ponatinib.<strong>&nbsp;</strong>It is also used in the treatment of&nbsp;<strong>accelerated</strong> and <strong>blast</strong> phases.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4191",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following can be used to assess the prognosis in patients with chronic myeloid leukemia?",
      "choices": [
        {
          "id": 1,
          "text": "Rai and Binet staging system"
        },
        {
          "id": 2,
          "text": "Ann Arbor staging system"
        },
        {
          "id": 3,
          "text": "Hasford scoring system"
        },
        {
          "id": 4,
          "text": "Matutes scoring system"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Hasford scoring system</strong> can be used to assess <strong>prognosis</strong> in patients with chronic myeloid leukemia (<strong>CML</strong>).</p>\n<p>The prognosis of CML can be assessed by:</p>\n<ul>\n<li><strong>Sokal score</strong>&nbsp;which is based on:\n<ul>\n<li>Age</li>\n<li>Spleen size</li>\n<li>Platelet count</li>\n<li>Percentage of blast cells in the blood</li>\n</ul>\n</li>\n<li>Hasford score<strong>&nbsp;</strong>- Similar to Sokal score, but additionally uses the percentage of eosinophils and basophils in the blood</li>\n</ul>\n<p>Option A:&nbsp;<strong>Rai and Binet </strong>staging system is used for staging chronic lymphocytic leukemia (<strong>CLL</strong>).</p>\n<p>Option B:&nbsp;<strong>Ann Arbor</strong> staging system is used in Hodgkin and non-Hodgkin&nbsp;<strong>lymphomas</strong>.</p>\n<p>Option D: <strong>Matutes</strong> scoring system is used for the diagnosis of <strong>CLL</strong> by flow cytometry.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2356",
      "difficulty": "medium"
    },
    {
      "text": "All of the following patients with chronic myeloid leukemia are in the accelerated phase except:<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Peripheral blast cell count &nbsp; &nbsp;</strong></td>\n<td><strong>Peripheral basophil count &nbsp; &nbsp;</strong></td>\n</tr>\n<tr>\n<td>Patient 1 &nbsp;&nbsp;</td>\n<td>&nbsp; &nbsp; &nbsp;20%</td>\n<td>&nbsp; &nbsp; &nbsp;15%</td>\n</tr>\n<tr>\n<td>Patient 2 &nbsp;&nbsp;</td>\n<td>&nbsp; &nbsp; &nbsp;10%</td>\n<td>&nbsp; &nbsp; &nbsp;25%</td>\n</tr>\n<tr>\n<td>Patient 3 &nbsp;&nbsp;</td>\n<td>&nbsp; &nbsp; &nbsp;13%</td>\n<td>&nbsp; &nbsp; &nbsp;21%</td>\n</tr>\n<tr>\n<td>Patient 4 &nbsp;&nbsp;</td>\n<td>&nbsp; &nbsp; &nbsp;15%</td>\n<td>&nbsp; &nbsp; &nbsp;14%</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "Patient 1"
        },
        {
          "id": 2,
          "text": "Patient 2"
        },
        {
          "id": 3,
          "text": "Patient 3"
        },
        {
          "id": 4,
          "text": "Patient 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>A blast count <strong>&ge; 20%</strong>&nbsp;in <strong>peripheral blood</strong> is indicative of a <strong>blast crisis</strong>, not the accelerated phase of chronic myeloid leukemia (<strong>CML</strong>).</p>\n<p>CML can be divided into three phases:</p>\n<ul>\n<li><strong>Chronic stable </strong>phase<strong>&nbsp;</strong>-&nbsp;<strong>Blasts &lt; 10%</strong> in peripheral blood and bone marrow</li>\n<li><strong>Accelerated </strong>phase - any of the following:\n<ul>\n<li><strong>Blasts</strong> comprising <strong>10-19%</strong> of white blood cells (WBCs) in peripheral blood and/or bone marrow</li>\n<li>Peripheral blood<strong> basophils &ge;20%</strong></li>\n<li>Thrombocytopenia or thrombocytosis not responsive to therapy</li>\n<li>Additional cytogenetic abnormalities in Philadelphia chromosome cells</li>\n</ul>\n</li>\n<li><strong>Blast crisis:</strong>\n<ul>\n<li><strong>Blasts &ge; 20%</strong> of peripheral blood WBCs or bone marrow</li>\n<li>Extramedullary blast proliferation</li>\n</ul>\n</li>\n</ul>\n<p>Majority of the patients present in the chronic stable phase. Without effective treatment, CML in the chronic phase will eventually move into an accelerated phase at first and then into the blast phase.</p><p>While the accelerated phase was an aggressive form of CML, the benefit of tyrosine kinase inhibitors and disease monitoring has successfully led to the&nbsp;<strong>omission of the accelerated phase</strong>&nbsp;of&nbsp;<strong>CML</strong>&nbsp;as per the&nbsp;<strong>5th edition of the WHO&nbsp;classification of hematolymphoid tumors.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2333",
      "difficulty": "medium"
    },
    {
      "text": "What is the classical immunophenotypic picture seen in patients with chronic lymphocytic leukemia?",
      "choices": [
        {
          "id": 1,
          "text": "CD19+, CD20+, CD21+, CD22+, CD 23+, CD5 +"
        },
        {
          "id": 2,
          "text": "CD19+, CD20+, CD21+, CD22+, CD23-, CD5+"
        },
        {
          "id": 3,
          "text": "CD79b+, CD19+, CD10+, CD20+, CD22+"
        },
        {
          "id": 4,
          "text": "CD79b+, CD19+, CD20+, CD22+, CD5-, CD10-"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The classical immunophenotypic feature seen in patients with chronic lymphocytic leukemia (<strong>CLL</strong>) is&nbsp;<strong>CD19+</strong>, CD20+, CD21+,CD22+,&nbsp;<strong>CD23+, CD5+.&nbsp;</strong>It is significant for&nbsp;<strong>coexpression</strong> of the <strong>B cell</strong>&nbsp;<strong>marker</strong> CD19 with the <strong>T cell marker</strong> CD5.&nbsp;</p>\n<p><strong>Mantle cell</strong> lymphoma has the same immunophenotype but with <strong>absent CD23.</strong>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>B cell precursors</strong></td>\n<td><strong>Derived lymphomas/leukemia</strong></td>\n<td>Immunophenotype</td>\n</tr>\n<tr>\n<td>Pro-B cell</td>\n<td>Pro-B cell ALL</td>\n<td>CD34,&nbsp;CD19, CD79a</td>\n</tr>\n<tr>\n<td>Pre-B cell</td>\n<td>Pre-B cell ALL</td>\n<td>CD19, CD79a,&nbsp;CD10, Tdt, Cytoplasmic Ig</td>\n</tr>\n<tr>\n<td>Mature B cell</td>\n<td>CLL/SLL</td>\n<td>\n<p>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD 23, CD5</p>\n</td>\n</tr>\n<tr>\n<td>Mantle zone</td>\n<td>Mantle zone lymphoma</td>\n<td>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD5</td>\n</tr>\n<tr>\n<td>Germinal center/Follicular center</td>\n<td>\n<p>Follicular lymphoma</p>\n<p>Diffuse large B cell lymphoma</p>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>CD 79b, CD 19, CD 20, CD22, CD10, CD 23, Bcl-2</p>\n<p>CD10, Cd23, Bcl-6</p>\n<p>CD10, CD23,Bcl-6</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Memory B cells</td>\n<td>Extranodal marginal zone lymphoma</td>\n<td>CD19, CD79a,CD 20, surface Ig</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4192",
      "difficulty": "medium"
    },
    {
      "text": "A 68-year-old man with fever is found to have a WBC count of 1,50,000/cu.mm. His peripheral smear study is given below. Which of the following is true about this condition?",
      "choices": [
        {
          "id": 1,
          "text": "It arises from the  myeloid lineage"
        },
        {
          "id": 2,
          "text": "Radiation exposure is a risk factor"
        },
        {
          "id": 3,
          "text": "It arises from the T lymphocytes"
        },
        {
          "id": 4,
          "text": "Patient may have autoimmune hemolytic anemia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The smear shows small round <strong>lymphocytes</strong> with scant cytoplasm and the presence of a <strong>smudge cell</strong>. The most probable diagnosis is chronic lymphocytic leukemia (<strong>CLL</strong>). Patients with CLL may have autoimmune hemolytic anemia (<strong>AIHA</strong>).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a609f4d7444143fc8177643b337e2d36x1280x1966.JPEG\" alt=\"Explanation Image\"><p><strong>Chronic lymphocytic leukemia</strong>/ small lymphocytic lymphoma refers to the monoclonal proliferation of mature <strong>B lymphocytes</strong>.&nbsp;It is more common in men than women. Increasing age and family history are important risk factors. CLL is one of the few leukemias <strong>not linked to radiation</strong> exposure.</p>\n<p>The majority of the patients are <strong>asymptomatic</strong> and are diagnosed during routine blood tests. Some patients may have <strong>painless lymphadenopathy</strong> and <strong>splenomegaly</strong>.&nbsp;Increased B cells may produce <strong>autoantibodies</strong> leading to autoimmune complications like autoimmune hemolytic anemia and immune thrombocytopenia (<strong>ITP</strong>).</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b0f88bbb9ba04b488380e527f8a0507e.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4194",
      "difficulty": "hard"
    },
    {
      "text": "What is the treatment of choice for a 71-year-old asymptomatic woman diagnosed with chronic lymphocytic leukemia?",
      "choices": [
        {
          "id": 1,
          "text": "Fludarabine only"
        },
        {
          "id": 2,
          "text": "Fludarabine + Chlorambucil + Rituximab"
        },
        {
          "id": 3,
          "text": "Chlorambucil + Bendamustine"
        },
        {
          "id": 4,
          "text": "Expectant management"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Expectant management</strong> is the treatment of choice for <strong>asymptomatic</strong> patients with chronic lymphocytic leukemia (<strong>CLL</strong>). This is because there is no clear survival benefit with chemotherapy in asymptomatic patients.</p>\n<p>Chemotherapy and monoclonal antibodies are used in the presence of the following features:</p>\n<ul>\n<li>Progressive marrow failure - worsening anemia, thrombocytopenia</li>\n<li>Progressive splenomegaly</li>\n<li>Progressive lymphadenopathy</li>\n<li>Presence of constitutional symptoms like weight loss, fever, night sweats</li>\n</ul>\n<p>Important drugs used in the management of CLL are <strong>fludarabine</strong>, <strong>cyclophosphamide</strong>, <strong>bendamustine</strong>, and <strong>rituximab</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2361",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is true about Richter syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Lymphadenopathy is absent"
        },
        {
          "id": 2,
          "text": "Transformation to an aggressive lymphoma"
        },
        {
          "id": 3,
          "text": "Decreased serum lactate dehydrogenase"
        },
        {
          "id": 4,
          "text": "Has a good prognosis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Richter's</strong> syndrome is the <strong>transformation</strong>&nbsp;of chronic lymphocytic leukemia (<strong>CLL</strong>) to&nbsp;<strong>aggressive lymphoma</strong>, most commonly diffuse large B cell lymphoma (DLBCL).&nbsp;It has a <strong>poor prognosis.</strong></p>\n<p>Patients develop the following features:</p>\n<ul>\n<li>Fever, and weight loss</li>\n<li>Rapidly enlarging lymph nodes&nbsp;</li>\n<li>Elevated serum lactate dehydrogenase&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4193",
      "difficulty": "easy"
    }
  ]
}